Platform Specialty Products Corporation Announces Receipt of Final Regulatory Approvals for the Sale of Arysta LifeScience an...
January 24 2019 - 7:00AM
Preliminary Estimated Unaudited Full Year 2018 Results
Conference Call on January 28, 2019
Platform Specialty Products Corporation (NYSE:PAH) ("Platform"), a
global specialty chemicals company, announced today that all
regulatory approvals necessary to complete the previously-announced
sale of Platform’s Agricultural Solutions business, which consists
of Arysta LifeScience Inc. and its subsidiaries (collectively
“Arysta”), to UPL Corporation Ltd have been obtained. The Arysta
sale is expected to close on January 31, 2019.
Platform also announced today that it will host a conference
call for investors on Monday, January 28, 2019 at 8:30 a.m.
(Eastern Time) to provide preliminary estimated unaudited fourth
quarter and full year 2018 financial results. Platform will
also discuss its 2019 fiscal year outlook and longer-term vision
for the company following completion of the Arysta transaction.
To listen to the call by telephone, please dial 877-876-9173
(domestic) or 785-424-1667 (international) and provide the
Conference ID: PAHQ418. The call will be simultaneously webcast at
www.platformspecialtyproducts.com. A replay of the call will be
available for three weeks shortly after completion of the live call
at www.platformspecialtyproducts.com.
About Platform
Platform is a leading specialty chemicals company which
formulates a broad range of solutions that enhance the performance
of products people use every day. Developed in multi-step
technological processes, the Company's innovative solutions enable
its customers' manufacturing processes in several key industries,
including consumer electronic, communication infrastructure,
automotive, industrial surface finishing, consumer packaging and
offshore oil production and drilling.
More information on Platform is available at
www.platformspecialtyproducts.com.
Forward-looking Statements
This press release contains forward-looking statements,
including, but not limited to, statements related to the
timing of the completion of the sale of Arysta LifeScience and the
ability of the parties to close this transaction, including meeting
other closing conditions. Actual results could differ from those
projected due to numerous factors, including, without limitation,
the parties’ ability to successfully satisfy the closing conditions
and complete the proposed separation; the timing for completion;
unanticipated delays; and legal, tax and regulatory requirements.
Additional information concerning these and other factors that
could cause actual results to vary is, or will be, included in
Platform's periodic and other reports filed with
the Securities and Exchange Commission, including Platform's
annual report on Form 10-K for the year ended December 31,
2017. These forward-looking statements are made as of
the date of this press release and are based on management's
estimates, assumptions and expectations with respect to future
events and financial performance. Platform undertakes no obligation
to update any forward-looking statements, whether as a result of
new information, future events or otherwise.
CONTACT:
Investor Relations Contact:
Carey Dorman Corporate Treasurer and
VP, Investor Relations Platform Specialty Products
Corporation 1-561-406-8465
Media Contact:
Liz Cohen Managing Director
Kekst & Co. 1-212-521-4845
Platform Specialty Products (NYSE:PAH)
Historical Stock Chart
From Apr 2024 to May 2024
Platform Specialty Products (NYSE:PAH)
Historical Stock Chart
From May 2023 to May 2024